Eleonora Cinelli

Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice

Angelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli et al. · Clinical and Experimental Dermatology · 2021 · 95 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +11

Efficacy and safety of risankizumab in psoriasis patients who failed <scp>anti‐IL</scp> ‐17, anti‐12/23 and/or anti <scp>IL</scp> ‐23: Preliminary data of a real‐life 16‐week retrospective study

Matteo Megna, Gabriella Fabbrocini, Angelo Ruggiero et al. · Dermatologic Therapy · 2020 · 54 citations

Medicine, Immunology, Pharmacology +16

Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti‐ <scp>interleukin</scp> ‐17 treatment: A real‐life 52‐week retrospective study

Angelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli et al. · Dermatologic Therapy · 2020 · 53 citations

Medicine, Dermatology, Pharmacotherapy +17

Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period

Matteo Megna, Eleonora Cinelli, Lucia Gallo et al. · Archives of Dermatological Research · 2021 · 49 citations

Medicine, Dermatology, Pharmacotherapy +6

Real world practice indirect comparison between guselkumab and risankizumab: Results from an <scp>Italian</scp> retrospective study

Angelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli et al. · Dermatologic Therapy · 2021 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11